BrainsWay Ltd.
NASDAQ:BWAYMedical - Devices
Healthcare
$8.73 +0.35%
+$0.05 today
- Market cap
- $342.42M
- Beta
- 0.15
- P/E (TTM)
- 61.7
- EPS (TTM)
- $0.23
52W Low $5.42High $17.35
Volume 0.12M
Average 0.15M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
$18.16M
FY 2025 · Annual
+76.4% YoYInvesting Cash Flow
-$17.63M
FY 2025 · Annual
Financing Cash Flow
-$2.23M
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (6.46M) | (13.35M) | (4.2M) | 2.92M | 7.63M |
| Depreciation & Amortization | 1.69M | 1.53M | 1.34M | 1.77M | 1.54M |
| Deferred Income Tax | 43K | 315K | 251K | 538K | 77K |
| Stock-Based Compensation | 1.89M | 1.47M | 381K | 1.44M | 1.2M |
| Change in Working Capital | 1.07M | (1.45M) | 1.64M | 2.39M | 8.23M |
| Accounts Receivables | (849K) | 1.46M | 1.09M | (867K) | 611.82K |
| Inventory | (411K) | (3.6M) | (506K) | (920K) | (1.41M) |
| Accounts Payables | 289K | 0 | (327K) | 2.12M | (480.78K) |
| Other Working Capital | 2.04M | 685K | 1.38M | 2.06M | 9.52M |
| Other Non-Cash Items | 2.66M | 1.72M | 1.88M | 1.24M | (506.79K) |
| Operating Cash Flow | 884K | (9.76M) | 1.28M | 10.3M | 18.16M |
| Capital Expenditures | (2.24M) | 9.72M | (2.39M) | (3.79M) | (1.76M) |
| Acquisitions (Net) | 39.98M | 0 | 0 | 0 | 0 |
| Purchases of Investments | (40M) | (21K) | 0 | 0 | (15.89M) |
| Sales of Investments | 22K | 40.25M | 0 | 0 | 20.16K |
| Other Investing Activities | (39.98M) | 0 | (35.02M) | 35.08M | 0 |
| Investing Cash Flow | (42.22M) | 42.17M | (37.41M) | 30.31M | (17.63M) |
| Debt Repayment | (475K) | (533K) | (271K) | (424K) | (832K) |
| Common Stock Issued | 42.26M | 0 | 0 | 16.35M | 0 |
| Common Stock Repurchased | 0 | (52K) | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (269K) | (962K) | (755K) | 2.33M | (1.4M) |
| Financing Cash Flow | 41.52M | (1.55M) | (1.03M) | 18.26M | (2.23M) |
| Effect of Forex Changes | (224K) | (202K) | 90K | (47K) | 34.35K |
| Net Change in Cash | (40K) | 30.66M | (37.06M) | 58.83M | (1.67M) |
| Free Cash Flow | (1.35M) | (9.76M) | (1.1M) | 6.5M | 16.4M |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income$7.6M
+ D&A$1.5M
+ Stock-Based Comp$1.2M
+ Deferred Tax$77.0K
+ Working Capital$8.2M
- Other Non-Cash-$506.8K
= Operating Cash Flow$18.2M
- Capex-$1.8M
= Free Cash Flow$16.4M
Analysis
FY2025 free cash flow is $16.4M. FCF conversion is 214.9% of net income. Operating cash flow was $18.2M, with capex of -$1.8M. The largest bridge item is Working Capital at $8.2M.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 6-K | 6-K filing | Nov 10, 2026 | |
| 6-K | 6-K filing | Nov 10, 2026 | |
| 6-K | 6-K filing | Nov 2, 2026 | |
| 6-K/A | 6-K/A filing | Oct 26, 2026 | |
| 6-K | 6-K filing | Oct 26, 2026 |
Does BWAY generate free cash flow?
BrainsWay Ltd. (BWAY) generated $16.40M of free cash flow in fiscal 2025.
How much operating cash flow does BWAY produce?
Operating cash flow was $18.16M, before capital expenditures of $1.76M.
Continue the stock analysis
Jump to another research area for this company.